UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)   

x       Quarterly report pursuant Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended October 31, 2012

 

o       Transition report pursuant Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from____________  to_____________

 

Commission file number 333-145898

 

ZURVITA HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   26-0531863
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

 

800 Gessner Rd, Suite 110
Houston, Texas 77024
(Address of principal executive offices) (zip code)

 

 

(713) 464-5002
(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x       No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x    No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer    o Accelerated filer   o
Non-accelerated filer     o (Do not check if a smaller reporting company) Smaller reporting company   x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o       No x

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of December 15, 2012:

65,098,713 shares of common stock, par value $0.0001

 

 

 

 
 

 

 

 

ZURVITA HOLDINGS, INC.

 

FORM 10-Q

 

PART I - FINANCIAL INFORMATION

 

  Page No.
Item 1.   Financial Statements.  
   
Condensed Consolidated Balance Sheets – October 31, 2012 (Unaudited) and July 31, 2012 (Audited) 3
   
Condensed Consolidated Statements of Operations (Unaudited) – For the Three Months Ended October 31, 2012 and 2011 4
   
Condensed Consolidated Statements of Cash Flows (Unaudited) – For the Three Months Ended October 31, 2012 and 2011 5
   
Notes to Interim Condensed Consolidated Financial Statements 6
   
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations. 20
   
Item 3.   Quantitative and Qualitative Disclosures about Market Risk. 27
   
Item 4.   Controls and Procedures. 27

 

PART II - OTHER INFORMATION

 

  Page No.
   
   
Item 1.   Legal Proceedings. 27
   
Item 1a. Risk Factors. 27
   
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds. 27
   
Item 3.   Defaults Upon Senior Securities. 27
   
Item 4.   Mine and Safety Disclosures. 27
   
Item 5.   Other Information. 27
   
Item 6.   Exhibits. 28
   
Signatures 29

 

2
 

 

ZURVITA HOLDINGS, INC.

CONSOLIDATED BALANCE SHEET

 

       
      10/31/2012 (Unaudited)      

7/31/2012

(Audited)

 
ASSETS                
Current assets                
Cash   $ 443,432     $ 239,375  
Accounts receivable     571,194       347,535  
Deferred expenses     60,445       1,500  
Prepaid expenses     187,287       89,806  
Total current assets     1,262,358       678,216  
                 
Property, plant and equipment (net)     60,285       59,473  
                 
Merchant account deposit     490,455       213,651  
Total assets   $ 1,813,098     $ 951,340  
                 
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT        
Current liabilities                
Accounts payable   $ 578,606     $ 302,511  
Accounts payable - related party     129,992       125,998  
Notes payable - current     183,053       158,127  
Accrued expenses     1,196,970       837,244  
Deferred revenue     115,623       80,161  
Income tax payable           2,822  
Total current liabilities     2,204,244       1,506,863  
                 
Fair value of warrants     399,748       262,799  
Notes payable - related party     700,000       700,000  
Total liabilities     3,303,992       2,469,662  
                 
Redeemable preferred stock     8,825,291       8,825,291  
                 
Stockholders' deficit                
Common stock ($.0001 par value, 300,000,000 shares authorized; 73,160,954 and 69,498,713 shares issued and 12,750,954 and 61,498,713 shares outstanding as of October 31, 2012 and July 31, 2012, respectively)     7,316       7,316  
Additional paid-in capital     10,469,335       10,469,335  
Accumulated deficit     (20,182,836 )     (20,210,264 )
Treasury stock     (610,000 )     (610,000 )
Total stockholders' deficit     (10,316,185 )     (10,343,613 )
                 
Total liabilities, redeemable preferred stock and stockholders' deficit   $ 1,813,098     $ 951,340  

 

The accompanying notes are an integral part of these consolidated financial statements. 

 

3
 

 

ZURVITA HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the Three Months Ended  
    October 31,  
    2012     2011  
REVENUES                
Administrative websites   $ 362,020     $ 128,323  
Advertising sales           59,030  
Commissions     36,815       103,759  
Consumable products     5,628,700       897,490  
Marketing fees and materials     102,073       75,821  
Membership fees     17,094       45,862  
Total revenues     6,146,702       1,310,285  
                 
COST OF SALES                
Benefit and service cost     179,334       173,093  
Consumable products manufacturing cost     1,569,220       269,670  
Sales commissions     3,217,456       679,667  
Total cost of sales     4,966,010       1,122,430  
                 
GROSS PROFIT     1,180,692       187,855  
                 
OPERATING EXPENSES                
Depreciation     9,221       8,716  
Office related expenses     101,864       132,009  
Payroll and employee benefits     401,153       506,539  
Professional fees     102,903       217,505  
Selling and marketing     341,627       145,932  
Travel     34,548       20,402  
Total operating expenses     991,316       1,031,103  
                 
Income (loss) from operations before other income (expenses)     189,376       (843,248 )
                 
OTHER INCOME (EXPENSE)                
Gain on change in fair value of warrants     (136,948 )     228,400  
Gain on extinguishment of debt           80,753  
Interest expense     (25,000 )     (93,677 )
Loss on change in fair value of marketable securities           (32,800 )
Total other income (expense)     (161,948 )     182,676  
                 
Income (loss) before income taxes     27,428       (660,572 )
                 
Income taxes           583  
                 
Net income (loss)   $ 27,428     $ (661,155 )
                 
Basic and diluted earnings (loss) per share   $ 0.00     $ (0.01 )
                 
Basic and diluted weighted average number of common shares outstanding     12,750,954       61,537,843  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

4
 

 

 

ZURVITA HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

         

 

    For the Three Months Ended  
    October 31, 2012     October 31, 2011  
Cash flows from operating activities                
Net income (loss)   $ 27,428     $ (661,155 )
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:              
Amortization of note payable discount           51,721  
Depreciation     3,316       8,716  
Share-based compensation           29,725  
Loss (gain) on change in fair value of warrants     136,948       (228,400 )
Gain on extinguishment of debt           (80,753 )
Loss on change in fair value of marketable securities           32,800  
Changes in operating assets and liabilities                
Increase in accounts receivable     (223,657 )     (72,633 )
Decrease (increase) in deferred expenses     1,500       (64,106 )
Increase in prepaid expenses     (434,735 )      
Increase in accounts payable and accrued expenses     661,921       56,191  
Increase (decrease) in deferred revenue     35,462       (13,218 )
Net cash provided by (used in) operating activities     208,183       (941,112 )
                 
Cash flows from investing activities:                
Purchase of property and equipment     (4,126 )     (2,278 )
Net cash (used in) investing activities     (4,126 )     (2,278 )
                 
Cash flows from financing activities:                
Proceeds from borrowings           1,500,000.00  
Principal payments made on notes payable           (465,000 )
Net cash provided by financing activities           1,035,000  
                 
Net change in cash balance     204,057       91,610  
                 
Beginning cash     239,375       906  
                 
Ending cash   $ 443,432     $ 92,516  
                 
Supplemental disclosure of cash flow information                
Cash paid for interest   $ 24,817     $ 5,903  
                 
Cash paid for taxes   $ 50     $  

 

         

The accompanying notes are an integral part of these consolidated financial statements.

 

5
 

                          

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

 

NOTE 1 – NATURE OF OPERATIONS

 

Our consolidated financial statements include the accounts of Zurvita Holdings, Inc. (referred to herein as the “Company,” “Zurvita Holdings,” “we,” “us” or “our”) and our wholly-owned subsidiary Zurvita, Inc. (Zurvita). Material intercompany transactions and balances have been eliminated upon consolidation. Zurvita Holdings is a national network marketing company offering high-quality products targeting individuals and families with a strong foothold in small town America and expanding into national urban centers. Products are sold through Zurvita’s network of independent sales consultants.

  

Management’s Assessment of Liquidity

 

Since the Company’s inception, the Company has primarily met its operating cash requirements through equity contributions from The Amacore Group, Inc. (Amacore), who was the Company’s sole shareholder prior to July 30, 2009. Subsequent to July 30, 2009, the Company has sold several series of preferred stock for gross proceeds of $6.8 million to another related party. We are using the proceeds from the sale of preferred stock to subsidize the Company’s operations as the Company’s revenues and operating cash flows are not currently sufficient to support the Company’s current operations.

 

At October 31, 2012, the Company had negative working capital of approximately $942 thousand, an accumulated deficit of approximately $20.2 million and positive cash flows from operating activities of approximately $200 thousand. Since the date of inception, the Company has used approximately $9.9 million in operations.

 

Additional cash resources may be required should the Company not meet its sales targets, exceed its projected operating costs, wish to accelerate sales or complete one or more acquisitions or if unanticipated expenses arise or are incurred.  

 

The Company does not currently maintain a line of credit or term loan with any commercial bank or other financial institution and has not made any other arrangements to obtain additional financing.  We can provide no assurance that we will not require additional financing.  Likewise, we can provide no assurance that if we need additional financing that it will be available in an amount or on terms acceptable to us, if at all.  If we are unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms favorable to us, we may be unable to execute our business plan or pay our costs and expenses as they are incurred, which could have a material, adverse effect on our business, financial condition and results of operations.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

  

Revenue Recognition

 

Administrative Websites

 

Company’s independent representatives pay a fee to the Company entitling them to use of websites that facilitate their business operations.  Revenue is recognized ratably over the website subscription period.

 

Advertising Sales

 

The Company markets subscriptions to a service that facilitates the ability of customers, typically small business owners, to display commercial advertising via an on-line search directory.  Revenue is recognized ratably over the advertising subscription period.

 

Commissions

 

The Company is paid a commission for its sales of third-party products. Commissions are recognized as products are sold and services performed and the Company has accomplished all activities necessary to complete the earnings process.  

 

6
 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

Consumable Products

 

The Company markets a line of nutritional drinks under the “Zeal” umbrella. Revenue from the sale of these consumable products is recognized upon shipment of the product.

 

Marketing Fees and Materials

 

The Company also earns ancillary revenue from the sale of marketing materials to sales consultants.  Revenue is recognized when marketing materials are delivered.

 

Membership Fees

 

The Company recognizes revenues from membership fees as earned for the sales of other lifestyle discount benefit programs, such as household protection and personal financial services.  These arrangements are generally renewable monthly and revenue is recognized over the renewal period.  

 

Refunds and Chargebacks

 

The Company records a reduction in revenue for estimated refunds and chargebacks from credit card companies based upon actual history and management’s evaluation of current facts and circumstances.   Refunds and chargebacks totaled approximately $39 thousand and $13 thousand for the three months ended October 31, 2012 and 2011, respectively, and were recorded as a reduction of revenue in the accompanying statements of operations.  Estimates for an allowance for refunds and chargebacks totaling approximately $10 thousand is included in accrued expenses in the accompanying consolidated balance sheets as of October 31, 2012 and July 31, 2012, respectively.

 

Selling and Marketing Costs

  

The Company classifies merchant account fees, fulfillment costs and lead cost not identifiable with specific product sales within selling and marketing costs within the Statement of Operations.

 

Concentration of Credit Risk

 

All of the Company’s credit card processing is with one merchant processor, as well as all marketing sales commission payments are calculated by a third-party service provider.

 

Use of Estimates

 

The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including the allowance for sales refunds and chargebacks, capitalization of certain assets, depreciable/amortizable lives, impairment of long-lived assets, determination of amount of allowance for doubtful accounts, the fair value of marketable securities, the expected volatility of common stock, and the fair value of common stock and warrants as well as the allocation of proceeds from the issuance of debt and equity instruments.  We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above-described items, are reasonable.

Accounts Receivable

 

Accounts receivable are stated at estimated net realizable value. Accounts receivable are primarily comprised of balances due from memberships, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated and specific customer issues are reviewed to arrive at appropriate allowances. At October 31, 2012 and July 31, 2012, no allowance was deemed necessary therefore none was recorded.

 

7
 

 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

Property, Plant and Equipment

 

Property, plant and equipment are recorded at cost. The cost of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred. The Company provides for depreciation and amortization using the straight-line method over the estimated useful lives of the property as follows: computer hardware, 3 years; furniture and fixtures, 7 years; equipment and machinery, 5 years; and leasehold improvements, the shorter of the term of the lease or the life of the asset. When assets are retired or otherwise disposed of, the assets and related accumulated depreciation are eliminated from the accounts and the resulting gain or loss is reflected in the results of operations.

 

Share-Based Compensation

 

The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model incorporates assumptions as to dividend yield, volatility, an appropriate risk-free interest rate and the expected life of the option. Many of these assumptions require management’s judgment. The Company’s stock volatility assumption is based upon its historical stock price fluctuations. The Company uses historical data to estimate option forfeiture rates and the expected term of options granted. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve at the time of grant.

 

Convertible Instruments

 

The Company reviews the terms of convertible debt and preferred stock for indications requiring bifurcation, and separate accounting for the embedded conversion feature. Generally, embedded conversion features where the ability to physical or net-share settle the conversion option is not within the control of the Company or the number of shares is variable are bifurcated and accounted for as derivative financial instruments. (See Derivative Financial Instruments below.) Bifurcation of the embedded derivative instrument requires allocation of the proceeds first to the fair value of the embedded derivative instrument with the residual allocated to the host instrument. The resulting discount to the debt instrument or to the redemption value of convertible preferred securities is accreted through periodic charges to interest expense over the term of the note or to dividends over the period to earliest conversion date using the effective interest rate method, respectively.

 

Derivative Financial Instruments

 

The Company does not use derivative financial instruments to hedge exposures to cash-flow or market risks. However, certain other financial instruments, such as warrants to purchase the Company’s common stock and the embedded conversion features of debt and preferred instruments that are not considered indexed to the Company’s common stock are classified as liabilities when either (a) the holder possesses rights to net-cash settlement, (b) physical or net share settlement is not within the control of the Company, or (c) based on its anti-dilutive provisions. In such instances, net-cash settlement is assumed for financial accounting and reporting. Such financial instruments are initially recorded at fair value and subsequently adjusted to fair value at the close of each reporting period. Fair value for option-based derivative financial instruments is determined using the Black-Scholes Option Pricing Model.

 

Income Taxes

 

The Company accounts for income taxes using an asset and liability method pursuant to which deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided against deferred tax assets based on the weight of available evidence when it is more likely than not that some or all of the deferred tax assets will not be realized.

 

8
 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

 

When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, we believe it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest and penalties associated with unrecognized tax benefits are classified as income tax expense in the statement of operations.

 

Fair Value Measurements

 

U.S. GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability to a third party with the same credit standing (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In many cases, the exit price and the transaction (or entry) price will be the same at initial recognition. However, in certain cases, the transaction price may not represent fair value. Fair value is a market-based measurement determined based on a hypothetical transaction at the measurement date, considered from the perspective of a market participant, not based solely upon the perspective of the reporting entity. When quoted prices are not used to determine fair value, consideration is given to three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. Entities are required to determine the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs. Inputs to fair valuation techniques are prioritized, allowing for the use of unobservable inputs to the extent that observable inputs are not available. The applicable guidance establishes a three-level hierarchy, based on the priority of the inputs to the respective valuation technique. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). An asset or liability’s classification within the fair value hierarchy is based on the lowest level of significant input to its valuation. The input levels are defined as follows:

 

Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities.

 

Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities.  Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. Level 3 assets and liabilities include those whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as those for which the determination of fair value requires significant management judgment or estimation.

Earnings (Loss) Per Share

 

Basic earnings (loss) per share is calculated by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is calculated by dividing the net income (loss) by the weighted average number of shares of common stock outstanding for the period, adjusted for the dilutive effect of common stock equivalents, using the treasury stock method. Convertible debt and warrants, officer, employee and non-employee stock options that are considered potentially dilutive are included in the fully diluted shares calculation as long as the effect is not anti-dilutive. Contingently issuable shares are included in the computation of basic loss per share when the issuance of the shares is no longer contingent.

 

Subsequent Events

 

Management has evaluated subsequent events through the date the financial statements were issued. 

9
 

 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

NOTE 3 – NON CASH INVESTING AND FINANCING ACTIVITIES

 

The following table presents a summary of the various noncash investing and financing transactions that the Company entered into during the three months ended October 31,

 

    2012     2011  
                 
                 
                 
Financed insurance agreement     24,927       20,190  
                 
Interest converted to principal           34,080  

 

 

NOTE 4 – NOTES PAYABLE

 

Notes payable consist of the following:

 

    10/31/2012
(Unaudited)
    7/31/2012
(Audited)
 
                 
                 
Financing agreement; bearing interest at 4.65% per annum; payable in monthly installments of approximately $2.7 thousand due through Oct 2012     24,927        
                 
Related party promissory notes payable; bearing interest of 10% per annum; unsecured; due on December 31, 2013     100,000       100,000  
                 
Related party promissory notes payable; bearing interest of 10% per annum; unsecured; due on December 31, 2013     600,000       600,000  
                 
Promissory note payable; bearing interest of 7.5% per annum; unsecured; principal payments due monthly approximately $27 thousand through July 2011; currently in default     158,127       158,127  
                 
                 
Total notes payable     883,054       858,127  
                 
Less current portion     183,054       158,127  
                 
Total long-term debt   $ 700,000     $ 700,000  

 

On April 20, 2012, the Company issued to Amacore an on-demand promissory note for $200 thousand. The note accrued interest at 15% per annum. The Company repaid the note payable plus accrued interest of $1 thousand.

 

On May 3, 2012, the Company issued to Mark Jarvis a promissory note for $100 thousand. The note accrued interest at 10% per annum and is due on December 31, 2013. As of October 31, 2012, the Company has not repaid the note plus accrued interest of $3.8 thousand.

 

10
 

  

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

On June 13, 2012, the Company issued to Vicis Capital Managment an on-demand promissory note for $600 thousand. The note accrued interest at 10% per annum and is due December 31, 2013. As of October 31, 2012, the Company has not repaid the note plus accrued interest of $29.7 thousand.

 

The Company is in default with respect to the promissory note due July 2011. Consequently, the Company has accrued interest in accordance with the promissory notes’ default provision at an interest rate of 18%.

 

The following is a schedule of the future maturity payments required under the Company’s promissory notes payable.

 

As of October 31, 2012  
         
  Current     $ 183,054  
  2013       700,000  
        $ 883,054  

 

NOTE 5 - ACCRUED EXPENSES

 

Accrued expenses consist of the following at October 31, 2012 and July 31, 2012:

 

 

             
   

10/31/2012

(Unaudited)

   

7/31/2012

(Audited)

 
Commissions   $ 815,456     $ 461,295  
Interest     88,095       63,280  
Payroll     110,261       74,202  
Product           59,688  
Refund reserve     10,000       10,000  
Sales tax payable     132,645       93,544  
Services           30,000  
Unclaimed property     40,513       40,513  
Finance agreement           4,722  
Total   $ 1,196,970     $ 837,244  

 

NOTE 6 - DEFERRED REVENUE

 

Deferred revenue consists of the following at October 31, 2012 and July 31, 2012:

 

   

10/31/2012

(Unaudited)

   

7/31/2012

(Audited)

 
Advertising   $ 1,000     $ 3,261  
Consumable products     86,184       47,030  
Direct response media     24,939       24,939  
Member fees     3,500       4,931  
Total   $ 115,623     $ 80,161  

 

NOTE 7 – ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

 

Financial instruments which are measured at estimated fair value on a recurring basis in the consolidated financial statements include marketable securities, an embedded share conversion feature and non-compensatory warrants. The fair value of the marketable securities was determined by the market price as quoted on the OTC. The fair value of the share conversion feature and warrants was determined by an independent expert valuation specialist using the Black-Scholes Option Pricing Model.

 

11
 

 

 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

 

Assets and liabilities measured at estimated fair value and their corresponding fair value hierarchy is summarized as follows:

 

October 31, 2012
Fair Value Measurements at Reporting Date Using
(Unaudited)
                   
      Quoted Prices in  Active Markets for Identical Assets       Significant Unobservable Inputs       Total  
      (Level 1)       (Level 3)       Fair Value  
Share conversion feature   $     $     $  
Warrants           399,748       399,748  
Total liabilities   $     $ 399,748     $ 399,748  

 

July 31, 2012
Fair Value Measurements at Reporting Date Using
(Audited)
                   
      Quoted Prices in  Active Markets for Identical Assets       Significant Unobservable Inputs       Total  
      (Level 1)       (Level 3)       Fair Value  
Share conversion feature   $     $     $  
Warrants           262,800       262,800  
Total liabilities   $     $ 262,800     $ 262,800  

 

The Company has categorized its assets and liabilities measured at fair value into the three-level fair value hierarchy, as defined in Note 2, based upon the priority of inputs to respective valuation techniques. Assets included in the level 1 of the fair value hierarchy include marketable securities which are fair valued on a recurring basis using quoted market prices. Liabilities included within level 3 of the fair value hierarchy presented in the preceding table include a share conversion feature and noncompensatory warrants. The valuation methodology for liabilities within level 3 uses a combination of observable and unobservable inputs in calculating fair value.

 

The Company recorded an unrealized loss of $0 thousand and $33 thousand on its marketable securities for the three months ended October 31, 2012 and 2011, respectively. These losses have been included in the Statement of Operations caption “Loss on change in fair value of marketable securities.”

 

The changes in level 3 liabilities measured at fair value on a recurring basis during the three months ended October 31, 2012 and the year ended July 31, 2012 are summarized as follows:

12
 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

   

Balance

Beginning of

Period

    Issuance    

(Gain) Loss

Recognized in

Earnings from

Change in

Fair Value

   

Balance End

of Period

 
                                 
For the Period Ended October 31, 2012                                
Share conversion feature   $     $     $     $  
Warrants   $ 262,800     $     $ 136,948     $ 399,748  

 

   

Balance

Beginning of

Period

    Issuance    

(Gain) Loss

Recognized in

Earnings from

Change in

Fair Value

   

Balance End

of Period

 
                                 
For the Year Ended  July 31, 2012                                
Share conversion feature   $     $     $     $  
Warrants   $ 299,600     $     $ (36,800 )   $ 262,800  

 

For the three months ended October 31, 2012 and 2011, an unrealized loss of $137 thousand and an unrealized gain of $228 thousand, respectively, are included in earnings within the Statement of Operations caption “Gain on change in fair value of warrants.”

 

Fair Value of Financial Instruments

 

The fair values of accounts receivable, accounts payable and accrued expenses approximate their carrying values due to the short term nature of these instruments. The fair values of notes payable approximate their carrying amounts as interest rates on these obligations are representative of estimated market rates available to the Company on similar instruments.

 

NOTE 8—REDEEMABLE PREFERRED STOCK

 

The Company is authorized to issue 11.35 million shares of preferred stock with a par value of $0.0001 per share. The following table summarizes the Preferred Stock issuances and number of Preferred Shares outstanding:

 

         Shares Outstanding at 
 Preferred Stock     Date of         
 Issuance     Issuance     October 31, 2012     July 31, 2012 
 Series A     July 30, 2009                      1,750,000                   1,750,000
 Series B     October 6, 2009                      2,000,000                   2,000,000
 Series C     January 29, 2010                      1,000,000                   1,000,000
 Series C     June 3, 2010                      2,300,000                   2,300,000
 Series C     June 9, 2011                      1,500,000                   1,500,000
 Series C     December 28, 2011                      2,800,000                   2,800,000
                        11,350,000                 11,350,000

 

Series A, Series B and Series C Convertible Preferred Stock is collectively referred to herein as “Convertible Preferred Stock.”

 

Significant rights of the Convertible Preferred Stock are discussed below:

 

Dividends

 

The Convertible Preferred Stock does not accrue dividends.

 

13
 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

 

Voting Rights

 

Each holder of the shares of Convertible Preferred Stock shall have the right to the number of votes equal to the number of Conversion Shares then issuable upon conversion of the Convertible Preferred Stock held by such holder in all matters as to which shareholders are required or permitted to vote, and with respect to such vote, such holder shall have full voting rights and powers equal to the voting rights and powers of the holders of Common Stock, and shall be entitled to vote, together with the holders of Common Stock as a single class, with respect to any question upon which holders of Common Stock have the right to vote; provided, however, as to any holder of Convertible Preferred Stock, the right to vote such shares shall be limited to the number of shares issuable to such holder pursuant to certain beneficial ownership limitations (as listed below) as of the record date for such vote. To the extent permitted under applicable corporate law, but subject to certain limitations on corporate actions as disclosed below, the Corporation’s shareholders may take action by the affirmative vote of a majority of all shareholders of the Company entitled to vote on an action. Without limiting the generality of the foregoing, the Company may take any of the actions by the affirmative vote of the holders of a majority of the Convertible Preferred Stock and the Common Stock and other voting common stock equivalents, voting together as one class.

 

As long as any shares of Convertible Preferred Stock are outstanding, the Company shall not, without the written consent or affirmative vote of the holders of no-less than 51 percent of the then outstanding stated value of the Convertible Preferred Stock consenting or voting as a separate class from the common stock, the Company shall not, either directly or by amendment, merger, consolidation or otherwise:

 

(i)   amend its certificate or articles of incorporation in any manner that adversely affects the rights of the holders of Convertible Preferred Stock;

 

(ii)   alter or change adversely the voting or other powers, preferences, rights, privileges, or restrictions of the Convertible Preferred Stock;

 

(iii)   increase the authorized number of shares of preferred stock or  Convertible Preferred Stock or reinstate or issue any other series of preferred stock;

 

(iv)    redeem, purchase or otherwise acquire directly or indirectly any junior securities or any shares pari passu with the Convertible Preferred Stock;

 

(v)   directly or indirectly pay or declare any dividend or make any distribution in respect of, any junior securities, or set aside any monies for the purchase or redemption (through a sinking fund or otherwise) of any junior securities or any shares pari passu with the Convertible Preferred Stock;

 

(vi)   authorize or create any class of stock ranking as to dividends, redemption or distribution of assets upon a liquidation senior to or otherwise pari passu with the Convertible Preferred Stock; or

 

(vii) enter into any agreement with respect to any of the foregoing.

 

Liquidation Preferences

 

Upon any liquidation, dissolution or winding-down of the Company, whether voluntary or involuntary (a “Liquidation”), the holders of the shares of Convertible Preferred Stock shall be paid in cash, before any payment shall be paid to the holders of common stock, or any other junior stock, an amount for each share of Convertible Preferred Stock held by such holder equal to the sum of the Stated Value thereof (such applicable amount payable with respect to a share of Convertible Preferred Stock sometimes being referred to as the “Individual Preferred Liquidation Preference Payment” and with respect to all shares of Convertible Preferred Stock in the aggregate sometimes being referred to as the “Aggregate Liquidation Preference Payment”).  If, upon such liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, the assets to be distributed among the holders of shares of Convertible Preferred Stock shall be insufficient to permit payment to the holders of Convertible Preferred Stock of an aggregate amount equal to the Aggregate Liquidation Preference Payment, then the entire assets of the Corporation to be so distributed shall be distributed ratably among the holders of Convertible Preferred Stock (based on the Individual Preferred Liquidation Preference Payments due to the respective holders of Convertible Preferred Stock).

14
 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

The liquidation value of Series A, Series B and Series C Convertible Preferred Stock was $1.75 million, $2 million and $4.8 million, respectively, as of October 31, 2012.

 

Conversion Rights

 

Each share of Convertible Preferred Stock shall be convertible, at the option of the holder thereof, at any time after the original issue date (subject to beneficial ownership limitations as listed below), and without the payment of additional consideration by the holder thereof, into such number of fully-paid and nonassessable shares of common stock as is determined by dividing the Stated Value per share, by the Conversion Price in effect at the time of conversion. The Conversion Price originally for Series A, B and C shall be $0.0625, $0.25 and $0.25, respectively; provided, however, that the Conversion Price, and the rate at which shares of Convertible Preferred Stock may be converted into shares of common stock, shall be subject to adjustment as a result of stock dividends, stock splits, and subsequent equity sales at a price lower than the Convertible Preferred Stock’s Conversion Price. Shares of Convertible Preferred Stock converted into common stock shall be canceled and shall not be reissued.

 

At October 31, 2012, Series A, Series B and Series C Convertible Preferred Stock is convertible into 28 million, 8 million, 19.2 million, and 11.2 million common shares, respectively. If the Convertible Preferred Stock had been converted as of October 31, 2012, the aggregate market price of the common shares for Series A, Series B and Series C would have been approximately $980 thousand, $280 thousand, $672 thousand, and $392 thousand, respectively.

 

Beneficial Ownership Limitations

 

The Company shall not affect any conversion of the Convertible Preferred Stock, and a holder shall not have the right to convert any portion of the Convertible Preferred Stock, to the extent that, after giving effect to the conversion, such holder (together with such holder’s affiliates, and any other person or entity acting as a group together with such holder or any of such holder’s affiliates) would beneficially own in excess 4.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon conversion of Convertible Preferred Stock held by the applicable holder.  The Beneficial Ownership Limitation provisions may be waived by such holder, at the election of such holder, upon not less than sixty one (61) days’ prior notice to the Company, to change the Beneficial Ownership Limitation to 9.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of Convertible Preferred Stock held by the applicable holder and the provisions of this section shall continue to apply.  Upon such a change by a holder of the Beneficial Ownership Limitation from such 4.99% limitation to such 9.99% limitation, the Beneficial Ownership Limitation shall not be further waived by such holder.

 

Redemption Rights of the Company

 

Shares of the Convertible Preferred Stock shall be redeemable, in whole or in part, at the option of the Company, by resolution of its Board of Directors at any time after the original issue date and before the first (1st) anniversary of the original issue date at a price equal to one hundred and ten percent (110%) of the Stated Value.

 

Redemption Rights of Holder

 

The Convertible Preferred Stock is redeemable for cash in an amount representing the Stated Value of outstanding Convertible Preferred Stock. The following events give rise to a redemption triggering event:

 

· The Company shall be party to a change of control transaction;
· The Company shall fail to have available a sufficient number of authorized and unreserved shares of common stock to issue to such holder upon a conversion;
· Unless specifically addressed elsewhere in the Convertible Preferred Stock’s Certificate of Designation as a Triggering Event, the Corporation shall fail to observe or perform any other covenant, agreement or warranty contained in the Certificate of Designation, and such failure or breach shall not, if subject to the possibility of a cure by the Company, have been cured within 20 calendar days after the date on which written notice of such failure or breach shall have been delivered;
· There shall have occurred a bankruptcy event or material monetary judgment;

 

If the Company fails to pay the redemption amount as a result of a triggering event on the date it is due, interest will accrue at a rate equal to the lesser of 18% per year, or the maximum rate permitted by applicable law, accruing daily from the date of the triggering event until the amount is paid in full.

15
 

 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

Events that may result in the redemption for cash of preferred stock, and that are not within a company’s control may require the preferred stock to be classified outside of stockholders’ equity (in the mezzanine section). All of the above triggering events are presumed not to be within our control. Accordingly, these instruments are recorded in our balance sheet in the caption Redeemable Preferred Stock, which is outside of stockholders’ equity. Management estimates the probability of the triggering events to be remote due to the Company’s affiliation with stockholders that represent a majority of the outstanding common and preferred stock. Therefore, the carrying value of the preferred stock has not been increased to the full redemption value.

 

The reason the carrying value is not equal to the redemption amount is due to the allocation of value to certain warrants issued in connection with the preferred stock. The following table summarizes for each preferred stock issuance the value allocated to the warrants and preferred stock:

 

        Total     Value     Preferred Stock  
Preferred Stock   Date of   Proceeds     Allocated to     Carrying  
Issuance   Issuance   Received     Warrants     Amount  
Series A   July 30, 2009   $ 1,750,000     $ 539,000     $ 1,211,000  
Series B   October 6, 2009     2,000,000       930,838       1,069,162  
Series C   January 29, 2010     1,000,000       431,415       568,585  
Series C   June 3, 2010     2,300,000       598,000       1,702,000  
Series C   June 9, 2011     1,500,000       24,000       1,476,000  
 Series C    December 28, 2011     2,800,000       1,456       2,798,544  
 Total       $ 11,350,000     $ 2,524,709     $ 8,825,291  

 

NOTE 9 - COMMON STOCK

 

The Company has authorized 300 million common shares with a par value of $0.0001 per share. On all matters required by law to be submitted to a vote of the holders of common stock, each share of common stock is entitled to one vote per share.

 

On July 30, 2009, the Company granted Mr. Jarvis 1.8 million shares of common stock, to be held in escrow, in connection with the execution of an employment agreement. These shares will be issued to Mr. Jarvis in accordance with the vesting period or upon completion of certain performance measures. Due to the forward stock split, the amount of shares was increased to 7.2 million shares of common stock. The shares were subject to a vesting period in which 3.6 million shares vested on July 30, 2010 and July 30, 2011, respectively. The grant date fair value was approximately $306 thousand. As of October 31, 2011, all shares were vested and issued.

 

For the three months ended October 31, 2012 and 2011, approximately zero and $29 thousand, respectively, of stock-based compensation expense was recognized, as a result of various share issuances.

 

On July 31, 2009, the Company entered into a stock repurchase agreement with a majority shareholder to purchase 8 million shares for $210 thousand or $0.26 per share. The treasury stock was recorded at cost. Management’s plan is to retain these shares.

 

On May 8, 2012, the Company and Amacore entered into a Stock Purchase Agreement (the “Amacore Purchase Agreement”) whereby the Company purchased 37.21 million shares of the Company’s common stock from Amacore. Pursuant to the Amacore Purchase Agreement, the Company paid to Amacore a purchase price equal to $300 thousand. The treasury stock was recorded at cost.

 

On May 8, 2012, the Company and Infusion entered into a Stock Purchase Agreement (the “Infusion Purchase Agreement”) whereby the Company purchased 15.2 million shares of the Company’s common stock from Infusion. Pursuant to the Infusion Purchase Agreement, the Company paid to Infusion a purchase price equal to $100 thousand. The treasury stock was recorded at cost.

16
 

 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

 

NOTE 10–WARRANTS

 

During 2009, Zurvita’s Board of Directors adopted the 2009 Incentive Stock Plan (the 2009 Plan), pursuant to which we reserved for issuance 6 million shares of Zurvita common stock to be used as awards to employees, directors, consultants, and other service providers. The purpose of the 2009 Plan is to provide an incentive to attract and retain officers, consultants, advisors and employees whose services are considered valuable, to encourage a sense of proprietorship and to stimulate an active interest of such persons into Zurvita’s development and financial success. Under the 2009 Plan, Zurvita is authorized to issue incentive stock options intended to qualify under Section 422 of the Code, non-qualified stock options, stock appreciation rights, performance shares, restricted stock and long term incentive awards. The 2009 Plan is administered by the Board’s designated Compensation Committee. As of October 31, 2011, approximately 5.4 million total options were issued under the 2009 Plan.

 

The following table summarizes the status of all warrants outstanding and exercisable at October 31, 2012.

 

Outstanding Warrants  
Range of
Exercise Prices
  Number of
Warrants
   

Weighted

Average

Exercise Price

    Weighted Average Remaining Contractual Life in Years  
 $0.06 to $0.49     71,908,000     $ 0.17       4.36  
 $0.50 to $0.99     100,000     $ 0.75       2.28  
      72,008,000     $ 0.17       4.36  

 

 

Exercisable Warrants  

Range of

Exercise Prices

 

Number of

Warrants

   

Weighted

Average

Exercise Price

    Weighted Average Remaining Contractual Life in Years  
 $0.06 to $0.49     71,908,000     $ 0.17       4.36  
 $0.50 to $0.99     100,000     $ 0.75       2.28  
      72,008,000     $ 0.17       4.36  

 

Compensatory Equity Warrants

 

During the three months ended October 31, 2012, the Company issued compensatory equity warrants to purchase an aggregate of approximately 433 thousand shares of common stock.

 

Assumptions used to determine the fair value of the compensatory warrants granted during the three months ended October 31, 2012 and during the year ended July 31, 2012 are as follows.

 

    October 31, 2012   July 31, 2012
Expected dividends   0%   0%
Expected volatility   71%   70%
Risk free interest rate   0.32% - 0.62%   0.25% - 0.94%
Expected life   5 years   5 years

 

17
 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

 

The following table summarizes the activity for compensatory warrants classified as equity for the three months ended October 31, 2012.

 

   

Compensatory Equity

Warrants

   

Weighted Average

Exercise Price

   

Weighted Average Remaining Contractual

Term

   

Aggregate

Intrinsic

Value

 
Outstanding at July 31, 2012     5,608,000     $ 0.22       3.00     $  
Granted                        
Exercised                        
Cancelled or Expired                        
Outstanding at October 31, 2012     5,608,000     $ 0.22       2.75     $  
Exercisable at October 31, 2012     5,608,000     $ 0.22       2.57     $  

 

The total fair value of warrants vested during the year ended October 31, 2012 was approximately $177 thousand. The weighted average grant date fair value of warrants granted during the year ended July 31, 2012 and 2011 was $0 and $0, respectively.

 

A summary of the status of the Company's non-vested compensatory equity warrants as of October 31, 2012, and the changes during the three months ended October 31, 2012, is presented below.

 

    Compensatory Warrants     Weighted Average Grant-Date Fair Value  
Non-vested at July 31, 2012     37,500     $ 0.003  
Issued            
Vested     (37,500 )      
Exercised            
Non-vested at October 31, 2012         $  

 

Non-compensatory Liability Warrants

 

There were approximately 66.4 million non-compensatory warrants outstanding as of October 31, 2012, all of which were classified as liabilities. These warrants are classified as liability instruments as net share settlement is not considered within the Company’s control or certain exercise prices are not fixed which has the potential to cause a variable number of shares and/or value exchange upon exercise.

 

The fair value of each option award classified as a liability on the balance sheets is estimated on the date of the grant using the Black-Scholes Pricing Model and the assumptions noted in the following table. The stock price used approximates the market price less a marketability discount of 30%. Expected volatility was determined by independent valuation specialist. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury Strip yield curve in effect at the time of grant. The expected term of options granted represents the period of time that options granted are expected to be outstanding.

 

Assumptions used to determine the fair value of the non-compensatory warrants outstanding during the three months ended October 31, 2012 and granted at and during the year ended July 31, 2012 are as follows.

 

    October 31, 2012   July 31, 2012
Expected dividends   0%   0%
Expected volatility   71%   70%
Risk free interest rate   0.53% - 1.04%   0.69% - 1.28%
Expected life   7 years   7 years

18
 

 

 

ZURVITA HOLDINGS, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED

(UNAUDITED)

 

There were no vested or non-vested compensatory liability issuances, exercises or expirations during the three months ended October 31, 2012.

Stock-Based Compensation Expense

For the three months ended October 31, 2012 and 2011, the Company recognized stock-based compensation expense, including both expense related to compensatory warrants and expense related to share awards, with the Statement of Operations as follows:

   

For the

Three Months Ended 

October 31, 2012

   

For the

Three Months Ended  

October 31, 2011

 
Payroll and employee benefits   $     $ 29,725  
Total   $     $ 29,725  

NOTE 11 - RELATED PARTY TRANSACTIONS

 

Commissions Paid

 

There are immediate family members of Mr. Jarvis, who operate as independent sales consultants who were paid commission compensation which approximated $57 thousand, respectively, for the three months ended October 31, 2012, and approximately $27 thousand, respectively, for the three months ended October 31, 2011. These payments were for work they performed on behalf of the Company.

 

Note Payable to Mark Jarvis

 

On July 19, 2011, the Company issued to Mark Jarvis an on-demand promissory note for $20 thousand. The note accrued interest at 15% per annum. As of October 31, 2012, the Company had repaid the note plus accrued interest of $99.

 

On June 13, 2012, the Company issued to Mark Jarvis an on-demand promissory note for $100 thousand. The note accrued interest at 10% per annum. As of October 31, 2012, the Company had not repaid the note plus accrued interest of $3.8 thousand.

 

Note Payable to Vicis Capital Management

 

On May 3, 2012, the Company issued to Vicis Capital Management an on-demand promissory note for $600 thousand. The note accrued interest at 10% per annum. As of October 31, 2012 the Company had not repaid the note plus accrued interest of $29.7 thousand.

 

 

 

 

 

 

19
 

Item 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Information contained in this discussion, other than historical information, is considered “forward-looking statements” that are subject to risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our business, financial condition, liquidity, results of operations, plans and objectives including, without limitation, statements about the Company’s ability to continue operations through October 31, 2012, the liability of the Company for claims made in pending litigation, plans for future products, strengthening our relationship with our various sales organizations, our marketing intentions, our anticipated products, efforts to expand distribution channels, Zurvita Holdings Inc. (“Zurvita”) anticipated growth in sales and margins, and our ability to achieve profitability. In some cases, you may identify forward-looking statements by words such as “may,” “should,” “plan,” “intend,” “potential,” “continue,” “believe,” “expect,” “predict,” “anticipate” and “estimate,” the negative of these words or other comparable words.  These statements are only predictions.  One should not place undue reliance on these forward-looking statements.  The forward-looking statements are qualified by their terms and/or important factors, many of which are outside the Company’s control, involve a number of risks, uncertainties and other factors that could cause actual results and events to differ materially from the statements made. The forward-looking statements are based on the Company’s beliefs, assumptions and expectations of our future performance, taking into account information currently available to the Company.  These beliefs, assumptions and expectations can change as a result of many possible events or factors, including those events and factors described in “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended July 31, 2012 filed with the Securities and Exchange Commission on November 14, 2012 (the “2011 Annual Report”), not all of which are known to the Company.  If a change occurs, the Company’s business, financial condition, liquidity and results of operations may vary materially from those expressed in the aforementioned forward-looking statements. The Company will update this forward-looking information only to the extent required under applicable securities laws.  Neither the Company nor any other person assumes responsibility for the accuracy or completeness of these forward-looking statements.

 

The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and notes thereto, and other financial information included elsewhere in this Form 10-Q.

 

Introduction

 

Management’s discussion and analysis of results of operations and financial condition (“MD&A”) is provided as a supplement to and should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes thereto included elsewhere herein to help provide an understanding of our financial condition and results of our operations. The MD&A is organized as follows:

 

  · Overview – This section provides a general description of our business.

 

  · Results of operations –  This section provides an analysis of our results of operations comparing the three months ended October 31, 2012 and 2011.  This analysis is provided on a consolidated basis.

 

  · Liquidity and capital resources  – This section provides an analysis of our cash flows for the three months ended October 31, 2012 and 2011 as well as a discussion of our liquidity and capital resources.

 

Overview

 

Description of Business

 

Our consolidated financial statements include the accounts of Zurvita Holdings, Inc. (referred to herein as the “Company,” “Zurvita Holdings,” “we,” “us” or “our”) and our wholly-owned subsidiary Zurvita, Inc. (Zurvita). Material intercompany transactions and balances have been eliminated upon consolidation. Zurvita Holdings is a national network marketing company offering high-quality products and services targeting individuals, families and small businesses. Products are sold through Zurvita’s network of independent sales consultants.

 

Business Strategy

 

Zurvita’s business model embraces a direct sales approach that utilizes the power of network marketing.  The business strategy relies on a marketing sales force that compensates independent business owners (“Consultants”) not only for sales of Company products and services they personally generate, but also for the sales of other Consultants whom they introduced to the business, creating a sales organization of Consultants and a hierarchy of multiple levels of compensation.  The products, services and business opportunities are typically marketed directly to potential business partners, consumers and small businesses by means of referrals, national advertising, video promotions, conferences, the Internet, and word-of-mouth marketing.

20
 

 

Consultants become associated with the Company through an independent contractor relationship and receive remuneration for selling products and services and for expanding their network of people doing the same by promoting Zurvita’s business opportunity. This model provides each independent sales Consultant an opportunity to earn money on a part-time basis or make a living on a full-time basis and to obtain long-term financial security through creating long-term residual income.

 

In February 2011 Zurvita entered into the growing Health & Wellness industry with its launch of “Zeal”, a nutritional drink, and entered the weight management market with the launch of Zurvita’s Zeal Weight Management Program in October 2011.

Zurvita has developed business processes to dramatically increase performance success:

 

Strengthen Brand Recognition

 

National and regional marketing efforts are administrated to support corporate and “personal” branding initiatives.  Inherent to the network marketing industry is the axiom that people do not follow products or features, but rather the people with whom they relate to on a personal level.  Zurvita not only invests resources to promote its corporate brand, but has developed a technological platform allowing Consultants to build web-based personal branded sites enhancing their position as affiliate marketers of Zurvita programs and services.

 

Increase Product and Service Offerings

 

Zurvita continues to explore the marketplace for new products and services that are anticipated by consumers. These are essential consumer and business solutions in large and growing markets. The network marketing industry mandates a state of continuous improvement by offering its Consultants and customers products and services that offer time, value and conveniences at cost competitive prices. Zurvita added to it’s Zeal for Life program, renowned fitness expert and motivational speak Peter Neilson whose partnership with Zurvita is training and consulting on wellness and fitness programs. Mr. Neilson’s dedication to health, fitness and lifestyle have propelled him to the top of the world of body building, earning Nielsen titles like Mr. International Universe, Mr. World and well over 50 others.

 

 

Marketing

 

Zurvita’s marketing strategies open new, innovative marketing and sales avenues for Consultants to build income through expansion of their sales organization and the residual benefits offered through the sale of health and wellness products. The marketing strategy features unique components beyond the traditional approach indicative of most network marketing companies.

 

Technology

 

Zurvita recognizes the Internet is a powerful platform for the network marketer. The highly social aspect of the Internet lends itself as a natural marketing vehicle and continuously opens a new population of prospects. Zurvita offers Consultants robust “back office” support complimented with sales and marketing tools.

 

Training and Support

 

The success of an external marketing program is only as effective as the internal marketing strategies to keep Consultants informed and engaged. Zurvita is committed to a variety of communication initiatives that promote leadership and business effectiveness. Weekly telephone/webinar meetings as well as informational seminars create opportunities to develop leaders and to promote Zurvita’s business opportunity. National conferences and regional events further support Zurvita’s efforts to train and develop its national sales force.

21
 

 

RESULTS OF OPERATIONS

 

   

For the

Three Months Ended October 31, 2012

   

For the

Three Months Ended October 31, 2011

   

Increase

(Decrease)

 
                         
Revenues   $ 6,146,702     $ 1,310,285     $ 4,836,417  
Cost of Sales     4,966,010       1,122,430       3,843,580  
                         
Gross Profit     1,180,692       187,855       992,837  
                         
Operating Expenses     991,316       1,031,103       (39,787 )
Operating Income (Loss)     189,376       (843,248 )     1,032,624  
                         
Other (Loss) Income     (161,948 )     182,676       (344,624 )
                         
Income (Loss) Before Income Taxes     27,428       (660,572 )     688,000  
                         
Income Taxes           583       (583 )
                         
Net Income (Loss )   $ 27,428     $ (661,155 )   $ 688,583  
                         
Basic and Diluted Earnings (Loss) Per Share   $ 0.002     $ (0.01 )        

 

 

Revenue:

 

For the three months ended October 31, 2012 and October 31, 2011, total revenue was $6.1 million and $1.3 million respectively. Due to the Company’s new, consumable product that launched subsequent to October 31, 2011, Zurvita has realized a $4.8 million increase over a one year period. The various components of total revenue are discussed below.

 

Administrative Websites

Administrative website sales were approximately $362 thousand for the three months ended October 31, 2012, as compared to approximately $128 thousand for the three months ended October 31, 2011. Since the Company’s launch of Zeal, the Company has experienced a significant increase in new consultants joining the business resulting in increased administrative websites.

 

Advertising Sales

The Company’s advertising sales were $0 thousand for the three months ended October 31, 2012, as compared to approximately $59 thousand for the three months ended October 31, 2011. The Company divested itself of Zlinked due to the technical shortcomings of the sales technology platform.

Commissions

The Company’s commission revenue for the three months ended October 31, 2012, was approximately $37 thousand as compared to approximately $104 thousand for the three months ended October 31, 2011. The approximate $67 thousand decrease is due to run off of the Company’s residential energy block of business The Company did not market residential energy during the year ended July 31, 2012.

Consumable Products

The Company’s consumable products revenue represents Zeal product sales. For the three months ended October 31, 2012, consumable products revenue was approximately $5.6 million and $898 thousand for the three months ended October 31, 2011. The Company has experienced significant growth percentages month over month resulting in the $4.8 million increase in a 12 month period.

22
 

 

 

Marketing Fees and Materials

The Company’s marketing fees and materials revenue for the three months ended October 31, 2012, was approximately $102 thousand as compared to approximately $75 thousand for the three months ended October 31, 2011. The company continues to provide marketing materials to the consultants for purchase.

 

Membership Fees

The Company’s membership fees were approximately $17 thousand for the three months ended October 31, 2012, as compared to $45 thousand for the three months ended October 31, 2011. The decrease in membership revenue is a result of the Company’s efforts to focus on the sale of consumable products.

Cost of Sales:

 

Total cost of sales for the three months ended October 31, 2012, was approximately $4.9 million as compared to approximately $1.1 million for the three months ended October 31, 2011. The increase is a direct result of the increased revenue from the sale of consumable products.

Benefit and Service Cost
Benefit and service cost represents the direct cost of the membership and subscription products sold such as administrative websites, marketing materials and membership fees. Benefit and service cost was approximately $179 thousand as compared to approximately $173 thousand.

Consumable Products Manufacturing Cost
Consumable products manufacturing cost represents Zeal’s manufactured cost and the cost of shipping the product to customers. For the three months ended October 31, 2012, the Company recognized $1.5 million and $270 thousand for the three months ended October 31, 2011. The increase is a direct result of the increased revenue from the sale of consumable products.

Sales Commissions
The Company pays its independent sales agents on a commission basis. Sales commissions for the three months ended October 31, 2012, were approximately $3.2 million as compared to approximately $680 thousand for the three months ended October 31, 2011. The increase of $2.5 million is the direct result of the increased revenue from the sale of consumable products.

Gross Profit:

 

For the three months ended October 31, 2012, gross profit was approximately $1.2 million or 19%, as compared to approximately $188 thousand or 14% for the three months ended October 31, 2011. The Company started the year with a very aggressive compensation plan on the consumable products that was later scaled back to increase margins and increase gross profit. The increase is a reflection of the changes.

 

Operating Expenses:

 

Our operating expenses for the three months ended October 31, 2012 and for the three months ended October 31, 2011, were approximately $991 thousand and $1.0 million, respectively. The Company has continued to bring the operating expenses under control and operating on a tight budget.

 

The table below sets forth components of our operating expenses for the three months ended October 31, 2012, compared to the corresponding prior year period:

 

   

For the

Three Months Ended October 31, 2012

   

For the

Three Months Ended October 31, 2011

   

Increase

(Decrease)

 
                         
Depreciation     9,221       8,716       505  
Office related expenses     101,864       132,009       (30,145 )
Payroll and benefits     401,153       506,539       (105,386 )
Professional fees     102,903       217,505       (114,602 )
Selling and marketing     341,627       145,932       195,695  
Travel     34,548       20,402       14,146  
                         
Total operating expenses   $ 991,316     $ 1,031,103     $ (39,787 )

 

Depreciation expense for the three months ended October 31, 2012, was approximately $9 thousand, approximately the same as the prior year period.

 

23
 

 

 

 

O ffice related costs include rent, insurance, utilities and office maintenance. For the three months ended October 31, 2012 these costs were approximately $102 thousand and approximately $132 thousand for the three months ended October 31, 2011, an overall decrease of approximately $30 thousand. 

 

Payroll and related expenses for the three months ended October 31, 2012 was approximately $401 thousand, a decrease of approximately $105 thousand over the same prior year period. The decrease is due to less recognition of stock based compensation.

 

Professional fees consist of consulting, accounting fees, contract labor and legal costs. For the three months ended October 31, 2012, these costs were approximately $102 thousand and $218 thousand for the three months ended October 31, 2011.  Significant reductions in accounting fees and contract labor led to an overall professional fees decrease of approximately $115 thousand.

 

Selling and marketing expenses for the three months ended October 31, 2012, were $342 thousand as compared to $146 thousand for the three months ended October 31, 2011, an increase of approximately $196 thousand over the prior reporting period. The significant increase is due to marketing efforts towards the sale of consumable products.

 

Busines s travel expenses for the three months ended October 31, 2012, were approximately $34 thousand, an increase of approximately $14 thousand as compared to the three months ended October 31, 2012.

 

Other Income (Expense):

 

Gain on change in fair value of warrants

 

The Company’s liability warrants are recorded at fair value. Their fair value is subject to remeasurement on a recurring basis. For the three months ended October 31, 2012 and 2011, the change in fair value of these warrants was approximately a loss of $137 thousand and a gain of $228 thousand, respectively. The loss in fair value for the three months end October 31, 2012 is a result of the decline in share price from $0.04 to $035 which is used as an input in fair valuing the warrants. The gain in fair value for the three months ended October 31, 2011 is a result of the increase in share price from $0.02 to $0.04. These gains are a non-cash item not impacting operating cash flows or results of operations before other income and expenses. See Note 7 – Assets and Liabilities Measured at Fair Value, to financial statements contained within Item 1 of Part 1 of this Form 10Q for additional information with respect to the estimation of the fair value of these warrants.

 

Interest expense

 

Interest expense for the three months ended October 31, 2012 was approximately $25 thousand, as compared to $94 thousand for the three months ended October 31, 2011.  The increase in interest expense is a result of accreting the discount recognized on the Company’s $2 million interest bearing convertible note issued on October 9, 2009. Accretion of $86 thousand is included within interest expense for the three months ended October 31, 2011, as compared to $78 thousand of accretion included within interest expense for the three months ended October 31, 2010.The decrease is a result of the prior period extinguishment of a $2 million interest bearing convertible note originally issued on October 9, 2009 and extinguished on May 8, 2012.

 

Loss on change in fair value of marketable securities

 

The Company’s marketable securities consist of non-registered common stock. The Company fair values these securities on a recurring basis. The Company recorded an unrealized loss of $0 for the three months ended October 31, 2012, as compared to the unrealized loss of $33 thousand recorded for the three months ended October 31, 2011. These losses are a non-cash item not impacting operating cash flows or results of operations before other income and expenses. See Note 7– Assets and Liabilities Measured at Fair Value, to financial statements contained within Item 1 of Part 1 of this Form 10-Q for additional information with respect to the determination of fair value for the Company’s marketable securities.

 

Income Taxes:

 

For the three months ended October 31, 2012, the Company estimated approximately $0 in tax expense as compared to $583 for the three months ended October 31, 2011.

 

The Company realized no federal tax benefit from the deferred tax asset resulting from its historical net operating loss carryforwards as the deferred tax asset is fully reserved.

 

Net Income (Loss):

 

The Com pany had net income of approximately $27 thousand for the three months ended October 31, 2012, as compared to a net loss of approximately $661 thousand for the three months ended October 31, 2011. The Company’s continued efforts towards increasing consumable product sales and maintaining a tight budget on operating expenses have resulted in the transition to net income from a net loss.

24
 

 

 

OFF BALANCE SHEET ARRANGEMENTS

 

We do not have any off balance sheet arrangements as of October 31, 2012.

 

LIQUIDITY AND CAPITAL RESOURCES

 

The following table compares our cash flows for the three month period ended October 31, 2012 to the corresponding prior period:

 

    October 31, 2012     October 31, 2011  
                 
Net cash provided by (used in) operating activities   $ 208,183     $ (941,112 )
Net cash used in investing activities     (4,126 )     (2,278 )
Net cash provided by financing activities           1,035,000  
                 
Net increase in cash   $ 204,057     $ 91,610  

 

Future minimum rental payments required under the Company’s operating leases that have initial or remaining non-cancelable lease terms in excess of one year on a fiscal year basis are as follows:

 

As of October 31, 2012:  
         
2013     $ 84,728  
2014       112,970  
2015       112,970  
        $ 310,668  

 

Since its inception, the Company has met its capital needs principally through sale of its equity securities and the issuance of debt. The proceeds from the sale of these securities have been used for the Company’s operating expenses, such as salary expenses, professional fees, rent expenses and other general and administrative expenses discussed above. At October 31, 2012, the Company had negative working capital of approximately $1.5 million, an accumulated deficit of approximately $20.2 million, and positive cash flows from operating activities of approximately $200 thousand.

 

During fiscal 2010, the Company raised from a shareholder $5.3 million of equity funding. During fiscal 2011, the Company raised from a shareholder $1.5 million of equity funding. In order to raise capital, the Company may sell additional equity or issued additional convertible debt securities which would result in additional dilution to our stockholders. The issuance of additional debt would result in increased expenses and could subject us to covenants that may have the effect of restricting our operations. We can provide no assurance that additional financing will be available in an amount or on terms acceptable to us, if at all. If we are unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms favorable to us, we may be unable to execute upon our business plan or pay our costs and expenses as they are incurred, which could have a material, adverse effect on our business, financial condition and results of operations.  Currently, the Company does not maintain a line of credit or term loan with any commercial bank or other financial institution. The Company has approximately $883 thousand and $858 thousand of outstanding notes payable as of October 31, 2012 and July 31, 2012, respectively.

 

CRITICAL ACCOUNTING POLICIES

 

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including the allowance for sales refunds and chargebacks, capitalization of certain assets, depreciable/amortizable lives, impairment of long-lived assets, determination of amount of allowance for doubtful accounts, the fair value of marketable securities, the expected volatility of common stock, and the fair value of common stock and warrants as well as the allocation of proceeds from the issuance of debt and equity instruments.  We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above-described items, are reasonable.

25
 

 

 

While all of our accounting policies impact the consolidated financial statements, certain policies are viewed to be critical. Critical accounting policies are those that are both most important to the portrayal of our financial condition and results of operations and that require management’s most subjective or complex judgments and estimates. Management believes the policies that fall within this category are the policies on revenue recognition and accounts receivable and other intangible assets, investments, financial and derivative instruments.

 

Revenue Recognition

 

Administrative Websites

 

Company’s independent representatives pay a fee to the Company entitling them to use of websites that facilitate their business operations.  Revenue is recognized ratably over the website subscription period.

 

Commissions

 

The Company is paid a commission for its sales of third-party products. Commissions are recognized as products are sold and services performed and the Company has accomplished all activities necessary to complete the earnings process.  

 

Consumable Products

 

The company markets a nutritional drink called “Zeal”. Revenue from the sale of this consumable product is recognized upon shipment of the product.

 

Marketing Fees and Materials

 

 

The Company also earns ancillary revenue from the sale of marketing materials to sales consultants.  Revenue is recognized when marketing materials are delivered.

 

Membership Fees

 

The Company recognizes revenues from membership fees as earned for the sales of other lifestyle discount benefit programs, such as household protection and personal financial services.  These arrangements are generally renewable monthly and revenue is recognized over the renewal period.  These products often include elements sold through contracts with third-party providers.  Based on consideration of each contractual arrangement, revenue is reported on a gross basis.

 

Fair Value Measurements

 

U.S. GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability to a third party with the same credit standing (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In many cases, the exit price and the transaction (or entry) price will be the same at initial recognition. However, in certain cases, the transaction price may not represent fair value. Fair value is a market-based measurement determined based on a hypothetical transaction at the measurement date, considered from the perspective of a market participant, not based solely upon the perspective of the reporting entity. When quoted prices are not used to determine fair value, consideration is given to three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. Entities are required to determine the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs. Inputs to fair valuation techniques are prioritized, allowing for the use of unobservable inputs to the extent that observable inputs are not available. The applicable guidance establishes a three-level hierarchy, based on the priority of the inputs to the respective valuation technique. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). An asset or liability’s classification within the fair value hierarchy is based on the lowest level of significant input to its valuation. The input levels are defined as follows:

 

Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities.

 

Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities.  Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. Level 3 assets and liabilities include those whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as those for which the determination of fair value requires significant management judgment or estimation.

 

 

26
 

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable

 

Item 4.  Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our principal executive and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q.  Based on this evaluation, our principal executive and principal financial officer concluded that our disclosure controls and procedures are ineffective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.  Presently, our disclosure controls and procedures are not designed adequately to provide reasonable assurance that such information is accumulated and communicated to our management. This conclusion was based on the material weaknesses identified with regard to internal controls over financial reporting, as described in the Company’s Annual Report for the year ended July 31, 2012.

 

There was no change in our internal control over financial reporting that occurred during the quarter covered by this Quarterly Report on Form 10-Q that materially affected, or is reasonably likely to materially affect, our control over financial reporting.

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

As of October 31, 2012, there was no material changes in the Company’s legal proceedings as previously disclosed in the Company’s 2012 Annual Report.

 

Item 1a. Risk Factors

 

Not applicable.

 

Item 2. Unregistered Sales of Equity and Use of Proceeds

 

Not applicable.

 

Item 3. Defaults Upon Senior Securities

 

Not applicable.

 

Item 4. Mine Safety Disclosures Not Applicable

 

Item 5. Other Information.

 

None

 

 

 

27
 

 

 

Item 6. Exhibits

 

(a) Exhibits:

 

   
31.2 Certification of the Co-Chief Executive Officer pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
32.1 Certification pursuant to Section 906 Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).

 

101.INS XBRL Instance Document
   
101.SCH XBRL Schema Document
   
101.CAL XBRL Calculation Linkbase Document
   
101.DEF XBRL Definition Linkbase Document
   
101.LAB XBRL Label Linkbase Document
   
101.PRE XBRL Presentation Linkbase Document

 

 

28
 

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated : March 14, 2013 /s/ Jay Shafer
  Jay Shafer
  Co-Chief Executive Officer
   

 

   

   

 

 

 

 

 

 

 

 

 

 

   

29
 

 

 

EXHIBIT INDEX

 

   
31.2 Certification of the Co-Chief Executive Officer pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
32.1 Certification pursuant to Section 906 Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).

 

101.INS XBRL Instance Document
   
101.SCH XBRL Schema Document
   
101.CAL XBRL Calculation Linkbase Document
   
101.DEF XBRL Definition Linkbase Document
   
101.LAB XBRL Label Linkbase Document
   
101.PRE XBRL Presentation Linkbase Document

 

 

 

 

 

 

 

   

30

 

 

Zurvita (CE) (USOTC:ZRVT)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Zurvita (CE).
Zurvita (CE) (USOTC:ZRVT)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Zurvita (CE).